Citadel Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-605,300
| Closed | -$60.1M | – | 10284 |
|
|
2019
Q3 | $60.1M | Sell |
605,300
-48,400
| -7% | -$4.6M | 0.03% | 654 |
|
|
2019
Q2 | $60.4M | Sell |
653,700
-340,400
| -34% | -$32.3M | 0.03% | 620 |
|
|
2019
Q1 | $93.8M | Sell |
994,100
-504,300
| -34% | -$44.1M | 0.05% | 388 |
|
|
2018
Q4 | $96M | Sell |
1,498,400
-210,400
| -12% | -$15.5M | 0.05% | 334 |
|
|
2018
Q3 | $153M | Sell |
1,708,800
-527,800
| -24% | -$46.6M | 0.07% | 260 |
|
|
2018
Q2 | $178M | Buy |
2,236,600
+32,900
| +1% | +$2.73M | 0.09% | 185 |
|
|
2018
Q1 | $197M | Buy |
2,203,700
+1,653,700
| +301% | +$159M | 0.11% | 131 |
|
|
2017
Q4 | $57.4M | Sell |
550,000
-360,200
| -40% | -$40.6M | 0.03% | 550 |
|
|
2017
Q3 | $133M | Sell |
910,200
-73,100
| -7% | -$9.96M | 0.1% | 169 |
|
|
2017
Q2 | $128M | Buy |
983,300
+155,500
| +19% | +$19.1M | 0.11% | 165 |
|
|
2017
Q1 | $103M | Buy |
827,800
+201,800
| +32% | +$24.1M | 0.09% | 192 |
|
|
2016
Q4 | $72.5M | Sell |
626,000
-10,000
| -2% | -$1.11M | 0.07% | 251 |
|
|
2016
Q3 | $66.5M | Buy |
636,000
+122,300
| +24% | +$13.2M | 0.07% | 278 |
|
|
2016
Q2 | $50.7M | Buy |
513,700
+11,500
| +2% | +$1.19M | 0.06% | 334 |
|
|
2016
Q1 | $50.3M | Sell |
502,200
-214,200
| -30% | -$22.1M | 0.06% | 297 |
|
|
2015
Q4 | $85.8M | Buy |
716,400
+34,500
| +5% | +$3.99M | 0.09% | 223 |
|
|
2015
Q3 | $73.8M | Buy |
681,900
+7,400
| +1% | +$918K | 0.07% | 282 |
|
|
2015
Q2 | $78.1M | Sell |
674,500
-89,100
| -12% | -$10.2M | 0.07% | 310 |
|
|
2015
Q1 | $88M | Sell |
763,600
-216,500
| -22% | -$25.9M | 0.08% | 263 |
|
|
2014
Q4 | $110M | Buy |
980,100
+167,800
| +21% | +$17.7M | 0.11% | 178 |
|
|
2014
Q3 | $77M | Buy |
812,300
+144,500
| +22% | +$13M | 0.08% | 249 |
|
|
2014
Q2 | $57.4M | Buy |
667,800
+46,600
| +8% | +$3.54M | 0.07% | 323 |
|
|
2014
Q1 | $43.4M | Sell |
621,200
-179,800
| -22% | -$14.2M | 0.05% | 452 |
|
|
2013
Q4 | $67.7M | Sell |
801,000
-224,000
| -22% | -$17.7M | 0.09% | 250 |
|
|
2013
Q3 | $78.9M | Buy |
1,025,000
+182,400
| +22% | +$12.8M | 0.12% | 174 |
|
|
2013
Q2 | $49.3M | Buy |
+842,600
| New | +$50.7M | 0.08% | 266 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Citadel Advisors's CELG Position: Q4 2019 in Review
Citadel Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,854,309 shares — an estimated $681M sold.
Citadel Advisors first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $681M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Citadel Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Citadel Advisors sold 6,854,309 Celgene Corp shares in Q4 2019, an estimated $681M.
- Citadel Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
- Citadel Advisors's Celgene Corp position peaked at $681M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.